Evidence map›Paper›PMID 42877048›Full record

ReviewFrontiers in pharmacology2026

Chemically modified gelatin derivatives: synthetic strategies, physicochemical properties, biodegradation, drug delivery and biomedical applications.

Amit Kunwar, J Aishwarya, Koushik Majee

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amit KunwarLife Sciences Discipline, Homi Bhabha National Institute, Mumbai, India.
J AishwaryaLife Sciences Discipline, Homi Bhabha National Institute, Mumbai, India.
Koushik MajeeRadiation and Photochemistry Division, Bhabha Atomic Research Centre, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gelatin, the hydrolysate of collagen, has been used as a food ingredient as well as a pharmaceutical excipient since ancient times. Of late, it has attracted renewed interest as a constituent of drug delivery systems (DDS) because of its amicability to easily transform into various structural forms such as hydrogel, nanoparticles, and microsphere among others. Further, to meet the requirements for the fabrication of DDS, researchers have attempted various kinds of chemical modifications of the native gelatin. Some of the major chemical modification strategies of gelatin include amination, thiolation, PEGylation, acrylation and selenation, among others. Increasing evidences so far have established that chemically modified derivatives of gelatin exhibit superior physicochemical properties compared to native gelatin to support drug delivery applications such as higher drug loading efficiency and improved drug release kinetics, biocompatibility, biodegradability and pharmacokinetic profile. Accordingly, chemically modified derivatives of gelatin have been preferred over native gelatin for biomedical applications. Moreover, the growing popularity of chemically modified derivatives of gelatin has prompted their commercial production. In view of these considerations, a dedicated review article summarizing the biochemistry of gelatin, various synthetic strategies used for the preparation of chemically modified derivatives of gelatin, mechanistic discussion on the superiority of the Physicochemical properties of gelatin derivatives along with recent progress and concerns linked to their biomedical applications, is warranted. The present review article addresses this objective by providing a comprehensive, critical, and up-to-date summary of chemically modified derivatives of gelatin.

Indexed as

biomedical applicationschemical modificationextractionGelatinmolecular structurephysicochemical properties

Identifiers

PMID42877048
PMCPMC13662600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.